Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

PPMI Investigators

Research output: Contribution to journalArticle

3 Scopus citations

Fingerprint Dive into the research topics of 'Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study'. Together they form a unique fingerprint.

Medicine & Life Sciences